OnabotulinumtoxinA Significantly Decreases Urinary Incontinence and Provides Treatment Benefit in Patients with Idiopathic Overactive Bladder: A Pooled Analysis of Two Phase III, Placebo-Controlled Pivotal Trials

Khullar V1, Nitti V2, Dmochowski R3, Sand P4, Chapple C5, Sievert K6, MacDiarmid S7, Radziszewski P8, Nardo C9, Zhou J9, Haag-Molkenteller C9, Herschorn S10

Abstract Category

Detrusor Overactivity

Abstract 175
Neurourology and Paediatrics
Scientific Podium Poster Session 19
Thursday 29th August 2013
15:00 - 15:05
113
Overactive Bladder Incontinence Urgency Urinary Incontinence
1. Imperial College, London, UK, 2. New York University Langone Medical Center, New York, NY, USA, 3. Vanderbilt University Medical Center, Nashville, TN, USA, 4. Evanston Continence Center, University of Chicago, Evanston, IL, USA, 5. Royal Hallamshire Hospital, Sheffield, UK, 6. University of Tuebingen, Tuebingen, Germany, 7. Alliance Urology Specialists, Greensboro, NC, USA, 8. Medical University of Warsaw, Warsaw, Poland, 9. Allergan, Inc., Irvine, CA, USA, 10. University of Toronto, Toronto, Ontario, Canada
Presenter
V

Vikram Khullar
Links

Abstract

20/04/2024 16:45:58